The development of renal cancer in two of our patients was intriguing in relation to Cybulski et al. who identified an increased risk of renal cancer associated with CHEK2, albeit in carriers of the CHEK2 I157T variant [23]. The gene discussed is CHEK2; the disease is renal carcinoma.